相关实验视频
Updated: May 14, 2025

07:54
Use of a Hanging-weight System for Isolated Renal Artery Occlusion
Published on: July 19, 2011
15.9K
接受连续脏置换治疗的重症患者是否需要调整塞法托林的剂量? 塞法托林PopPK模型和剂量模拟与基于回顾性数据的目标实现概率分析
Arkadiusz Adamiszak1,2, Krzysztof Pietrzkiewicz3, Alicja Bartkowska-Śniatkowska3
1Department of Pharmacology, Poznan University of Medical Sciences, 60-806 Poznan, Poland.
Antibiotics (Basel, Switzerland)
|April 29, 2025
概括
开发了Ceftaroline的种群药动力学模型,显示标准剂量对大多数感染有效. 然而,在接受连续脏替代疗法 (CRRT) 的脏清除率增强 (ARC) 患者中,对MRSA感染可能需要更高的剂量.
科学领域:
- 药理动力学和药理动力学
- 传染性疾病 传染性疾病
- 关键护理医学 关键护理医学
背景情况:
- 塞法托林是治疗严重感染的重要抗生素,包括由MRSA引起的感染.
- 在重症监护室 (ICU) 患者中,优化塞法托林剂量至关重要,特别是那些功能变化和持续置换疗法 (CRRT) 患者.
- 种群药动力学 (PopPK) 建模为了解不同患者种群中的药物处置提供了一个框架.
研究的目的:
- 开发一种强大的PopPK模型,用于ICU患者的Ceftaroline.
- 为了评估目前的Ceftaroline剂量方案在不同清和CRRT设置中的充分性.
- 为复杂患者群体提供基于证据的Ceftaroline剂量建议.
主要方法:
- 非线性混合效应建模 (Monolix 2024R1) 用于开发PopPK模型.
- 分析了29名非CRRT和4名CRRT患者的数据.
- 蒙特卡洛模拟和目标实现概率 (PTA) 分析 (Simulx 2024R1) 进行了评估剂量方案.
主要成果:
- 一个五分区模型最好地描述了塞法托林度,将清除率 (Cl) 和CRRT模式作为共同变量.
- 模拟表明,注册的塞法托林剂量达到S. pneumoniae和MRSA感染的目标PTA,除了MRSA在干净增加 (ARC) 的患者中.
- 该模型允许灵活的药理动力学模拟,适应CRRT设置的变化.
结论:
- 开发的PopPK模型可以实现动态的ceftaroline剂量模拟,可适应实时临床变化,包括CRRT状态.
- 目前的塞法托林剂量通常足够,但可能需要对CRRT上ARC患者的MRSA感染进行调整.
- 建议进行临床验证,因为在此分析中包含的CRRT患者数量有限.
相关概念视频
Renal Failure: Dose Adjustments
37
In patients with renal impairment, drugs undergo significant changes in their pharmacokinetics, which require dosage adjustments to ensure safe and effective therapy.
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
37
Factors Affecting Renal Clearance: Renal Impairment
35
Renal dysfunction significantly impairs the renal clearance of drugs, leading to potential complications in drug therapy. Renal failure, which can be caused by various factors, poses a significant challenge in the elimination of drugs from the body.
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
35
Renal Drug Clearance: Overview
81
Renal clearance is a crucial parameter in pharmacokinetics that quantifies the rate at which the kidneys excrete a drug. It represents a constant fraction of the central volume of distribution containing the drug that the kidney eliminates per unit of time.
Renal clearance can be calculated using different methods. One approach is to divide the urinary drug excretion rate by the plasma drug concentration. This method directly measures renal clearance, indicating the kidneys' efficiency in...
Renal clearance can be calculated using different methods. One approach is to divide the urinary drug excretion rate by the plasma drug concentration. This method directly measures renal clearance, indicating the kidneys' efficiency in...
81
Renal Drug Excretion: Tubular Secretion
94
Active tubular secretion is a robust, energy-demanding process that utilizes carrier systems to transport drugs into renal tubules. The active renal secretion systems include the organic anion transporter (OAT) for weak acids and the organic cation transporter (OCT) for weak bases. Structurally similar drugs can compete for the same transporter, potentially leading to drug accumulation and toxicity. However, this principle can be exploited therapeutically. One example is probenecid (Probalan),...
94
One-Compartment Model: IV Infusion
121
Intravenous (IV) infusion is often utilized when continuous and controlled drug delivery is necessary, such as during surgery or in the treatment of chronic diseases. This method offers numerous advantages, including immediate drug action, precise control over dosage, and bypassing the first-pass metabolism.
The one-compartment model for IV infusion uses mathematical equations to describe the rate of change in drug quantity in the body. At steady-state or infusion equilibrium, the drug input...
The one-compartment model for IV infusion uses mathematical equations to describe the rate of change in drug quantity in the body. At steady-state or infusion equilibrium, the drug input...
121
Factors Affecting Renal Clearance: Drug Distribution and Drug Interactions
71
Renal clearance plays a pivotal role in drug elimination from the body and can be influenced by drug distribution and interactions. Understanding these factors is crucial in pharmacology as they impact the effectiveness and duration of drug therapy.
One important factor is the relationship between renal clearance and the apparent volume of distribution. Renal clearance tends to be inversely proportional to the apparent volume of distribution. Drugs with an extensive distribution volume or those...
One important factor is the relationship between renal clearance and the apparent volume of distribution. Renal clearance tends to be inversely proportional to the apparent volume of distribution. Drugs with an extensive distribution volume or those...
71

